47 results
DRS/A
EX-10.24
CGTX
Cognition Therapeutics Inc
23 Jun 21
Draft registration statement (amended)
12:00am
in the NIH Grants Policy Statement, including addenda in effect as of the beginning date of the budget period.
Federal Award Performance Goals
DEF 14A
CGTX
Cognition Therapeutics Inc
25 Apr 22
Definitive proxy
5:28pm
The Compensation Committee reviews the performance and development of our management in achieving corporate goals and objectives and assures that our executive … paid, our Compensation Committee determined the level of achievement of the corporate goals and individual goals
for the year. These goals
8-K
EX-99.1
CGTX
Cognition Therapeutics Inc
30 Mar 22
Cognition Therapeutics Reports Year End 2021 Financial Results and Provides
7:29am
to aggressively pursue our goals.”
Business Updates:
Cognition’s lead program, CT1812, is currently enrolling patients with mild-to-moderate Alzheimer’s disease
S-1
EX-10.27
sj995a 7cd42xxc0751
19 Jul 21
IPO registration
7:02am
S-1
EX-10.25
vbwabdyrfie7zw0
19 Jul 21
IPO registration
7:02am
DRS/A
EX-10.22
owzj gre71x
23 Jun 21
Draft registration statement (amended)
12:00am
DRS/A
EX-10.27
0dtw2
23 Jun 21
Draft registration statement (amended)
12:00am
S-1
EX-10.28
4e8ny9z 06bt5y
19 Jul 21
IPO registration
7:02am
DRS/A
EX-10.25
19nb5giug
23 Jun 21
Draft registration statement (amended)
12:00am
DRS/A
EX-10.26
nqggxwhfmh5clu0p9vm
23 Jun 21
Draft registration statement (amended)
12:00am
S-1
EX-10.29
n926ffsbx38xpku8e96
19 Jul 21
IPO registration
7:02am
DRS/A
EX-10.30
ae62yl5z1mv
23 Jun 21
Draft registration statement (amended)
12:00am
S-1
EX-10.30
c10vk589wkpchfqb
19 Jul 21
IPO registration
7:02am
DRS/A
EX-10.21
irq kbla4tz3
23 Jun 21
Draft registration statement (amended)
12:00am
S-1
EX-10.33
p7adi2o3qr b1c1s2ua
19 Jul 21
IPO registration
7:02am
S-1
EX-10.24
q9kln44vbi
19 Jul 21
IPO registration
7:02am
S-1/A
EX-10.11
knyb55sz8ofdruvr8so
29 Jul 21
IPO registration (amended)
4:45pm